Do you know anyone suffering from eczema? Call Today – 855.554.6374
note: Qualified study participants will receive study drug, related testing, and compensation for their time and travel.
Clinical Trial Government Identifier #NCT03569293
|Genders eligible for study: Male/Female||Ages eligible for study: 18-75 years old|
|NEW STUDY, NOW ENROLLING – Moderate to Severe atopic dermatitis (eczema) present for at least 1 year; no prior use of dupilumab allowed||August 2018 – May 2022|